Michele Park
InvestorInvestor, Healthcare Team at New Enterprise Associates (NEA) · Board director at Abcuro
Find your path to Michele
137 people in our graph share verified history with Michele — schools, employers, funds. One of them is your warm intro.
About
Michele Park is an investor at New Enterprise Associates focused on the biopharma sector. She previously held investor roles at Clarus Ventures (now Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences, where she completed her dissertation at Memorial Sloan Kettering Cancer Center, and a BA in molecular biology from Princeton.
Invests in
Biotech
Board director at Abcuro
Intro paths
In turn, Michele can intro founders to Abcuro's investors below.
Abcuro's investors · 15
Co-founders at Abcuro
Colleagues at New Enterprise Associates (NEA)
Frequently asked questions
- Who is Michele Park?
- Michele Park is an investor at New Enterprise Associates focused on the biopharma sector. She previously held investor roles at Clarus Ventures (now Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences, where she completed her dissertation at Memorial Sloan Kettering Cancer Center, and a BA in molecular biology from Princeton.
- Where does Michele Park work?
- Michele Park is Investor, Healthcare Team at New Enterprise Associates (NEA) and Board director at Abcuro.
- What does Michele Park invest in?
- Michele Park invests in Biotech.